-
Product Insights
NewBreast Implants Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Breast Implants Pipeline Market Report Overview Breast Implants are also known as intensive-care ventilators. They provide artificial respiratory support to critical patients in ICUs. The Breast Implants pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments...
-
Product Insights
Stroke Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Stroke can occur with symptoms including sudden numbness in their face or limbs, particularly down one side of their body. The sufferer may appear confused and have trouble talking or understanding what is being said to them. They may have vision problems, and trouble walking or keeping their balance. The Stroke pipeline drugs market research report outlays comprehensive information on the Stroke targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA)...
-
Product Insights
Alzheimer’s Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Alzheimer's disease is a progressive, degenerative condition causing damage to memory and behavior due to the attack on the neurons. Predisposing factors include age, heredity, cardiovascular diseases or diabetes, and environmental factors. Symptoms include depression, anxiety, social withdrawal, irritability, and aggressiveness. The Alzheimer’s Disease Drugs in Development market research report provides an overview of the Alzheimer's Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Alzheimer's Disease, complete with analysis by stage of development, drug...
-
Product Insights
Aesthetic Implants Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021
The aesthetic implants report provides key information and data related to extensive coverage of the aesthetic implants under development. The report provides details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates. Aesthetic implants are devices intended to enhance the physical appearance and improve the image. Implantation is usually performed for cosmetic purposes as well as to rectify the deformed shape of the organ.
-
Product Insights
Optic Neuropathy Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Optic Neuropathy Global Clinical Trials Review, H1, 2018" provides an overview of Optic Neuropathy clinical trials scenario. This report provides top line data relating to the clinical trials on Optic Neuropathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
Acute Coronary Syndrome: Competitive Landscape to 2026
Acute coronary syndrome (ACS) refers to a spectrum of myocardial ischemic states caused by the disruption of atherosclerotic plaques in the coronary arteries. The syndrome is precipitated by coronary artery occlusion (stenosis), which results in ischemia and myocardial necrosis. The development of ACS is heavily influenced by diet and lifestyle, and can manifest as myocardial infarction (MI) or unstable angina (UA). This report provides an assessment of the pipeline, clinical, and commercial landscape of ACS. Overall, GlobalData expects new drug...
-
Thematic Analysis
Biomarkers in the Central Nervous System
Biomarkers in CNS are expected to be an area that will witness strong growth in the future due to factors such as deeper understanding of the underlying disease pathology, advancements in technologies, and potential of these biomarkers that can contribute to targeted therapy. Biomarkers in CNS targeting a number of neurology indications are being developed; however, the most common ones are Alzheimer’s disease (AD), Schizophrenia and Multiple Sclerosis (MS). This report provides an overview of current clinical and product development...